Trial · NCT01723202
Adverse events498
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 498
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm A: Dabrafenib Alone | 17 | 26 | 17 |
| other | Anemia | Blood and lymphatic system disorders | Arm B: Dabrafenib + Trametinib | 16 | 27 | 16 |
| other | Anemia | Blood and lymphatic system disorders | Crossover to Dabrafenib + Trametinib | 4 | 14 | 4 |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Arm A: Dabrafenib Alone | 4 | 26 | 4 |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Arm B: Dabrafenib + Trametinib | 4 | 27 | 4 |
| other | Blood and lymphatic system disorders - Other | Blood and lymphatic system disorders | Crossover to Dabrafenib + Trametinib | 0 | 14 | 0 |
| other | Atrial fibrillation | Cardiac disorders | Arm A: Dabrafenib Alone | 2 | 26 | 2 |
| other | Atrial fibrillation | Cardiac disorders | Arm B: Dabrafenib + Trametinib | 2 | 27 | 2 |
| other | Atrial fibrillation | Cardiac disorders | Crossover to Dabrafenib + Trametinib | 1 | 14 | 1 |
| other | Palpitations | Cardiac disorders | Arm A: Dabrafenib Alone | 2 | 26 | 2 |
| other | Palpitations | Cardiac disorders | Arm B: Dabrafenib + Trametinib | 0 | 27 | 0 |
| other | Palpitations | Cardiac disorders | Crossover to Dabrafenib + Trametinib | 3 | 14 | 3 |
| other | Sinus tachycardia | Cardiac disorders | Arm A: Dabrafenib Alone | 3 | 26 | 3 |
| other | Sinus tachycardia | Cardiac disorders | Arm B: Dabrafenib + Trametinib | 0 | 27 | 0 |
| other | Sinus tachycardia | Cardiac disorders | Crossover to Dabrafenib + Trametinib | 1 | 14 | 1 |
| other | Ear Pain | Ear and labyrinth disorders | Arm A: Dabrafenib Alone | 3 | 26 | 3 |
| other | Ear Pain | Ear and labyrinth disorders | Arm B: Dabrafenib + Trametinib | 0 | 27 | 0 |
| other | Ear Pain | Ear and labyrinth disorders | Crossover to Dabrafenib + Trametinib | 1 | 14 | 1 |
| other | Endocrine disorders - Other | Endocrine disorders | Arm A: Dabrafenib Alone | 2 | 26 | 2 |
| other | Endocrine disorders - Other | Endocrine disorders | Arm B: Dabrafenib + Trametinib | 1 | 27 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01723202/events